P16 Mediated Suppression Of Telomerase In Normal And Malignant Human Breast Cells.

Details

Ressource 1Download: BIB_BF17B87FFFFA.P001.pdf (921.14 [Ko])
State: Public
Version: author
Serval ID
serval:BIB_BF17B87FFFFA
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
P16 Mediated Suppression Of Telomerase In Normal And Malignant Human Breast Cells.
Journal
Aging Cell
Author(s)
Bazarov A.V., van Sluis M., Hines C., Bassett E., Beliveau A., Campeau E., Mukhopadhyay R., Lee W.J., Melodyev S., Zaslavsky Y., Lee L., Rodier F., Chicas A., Lowe S.W., Benhattar J., Ren B., Campisi J., Yaswen P.
ISSN
1474-9726[electronic], 1474-9718[linking]
Publication state
Published
Issued date
06/2010
Peer-reviewed
Oui
Pages
14 p.
Language
english
Notes
Publié en ligne
Abstract
Summary The cyclin-dependent kinase inhibitor p16(INK4a) (CDKN2A) is an important tumor-suppressor gene frequently inactivated in human tumors. p16 suppresses the development of cancer by triggering an irreversible arrest of cell proliferation termed cellular senescence. Here, we describe another anti-oncogenic function of p16 in addition to its ability to halt cell cycle progression. We show that transient expression of p16 stably represses the hTERT gene, encoding the catalytic subunit of telomerase, in both normal and malignant breast epithelial cells. Short-term p16 expression increases the amount of histone H3 trimethylated on lysine 27 (H3K27) bound to the hTERT promoter, resulting in transcriptional silencing, likely mediated by polycomb complexes. Our results indicate that transient p16 exposure may prevent malignant progression in dividing cells by irreversible repression of genes, such as hTERT, whose activity is necessary for extensive self-renewal.
Pubmed
Web of science
Create date
16/07/2010 16:30
Last modification date
20/08/2019 16:33
Usage data